Cargando…

SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10

BACKGROUND: SLC/CCL21, normally expressed in high endothelial venules and in T cell zones of spleen and lymph nodes, strongly attracts T cells and dendritic cells (DC). We have previously shown that SLC/CCL21-mediated anti-tumor responses are accompanied by significant induction of IFNγ and the CXC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Sherven, Yang, Seok-Chul, Hillinger, Sven, Zhu, Li X, Huang, Min, Batra, Raj K, Lin, Jeff F, Burdick, Marie D, Strieter, Robert M, Dubinett, Steven M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC155639/ https://www.ncbi.nlm.nih.gov/pubmed/12740040 http://dx.doi.org/10.1186/1476-4598-2-22

Ejemplares similares

Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
por: Rabquer, Bradley J, et al.
Publicado: (2011)

IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome
por: Maruoka, Hayato, et al.
Publicado: (2013)

MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitis
por: Tworek, Damian, et al.
Publicado: (2013)

Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic
por: Baresi, Giulia, et al.
Publicado: (2021)

An IP-10 (CXCL10)-Derived Peptide Inhibits Angiogenesis
por: Yates-Binder, Cecelia C., et al.
Publicado: (2012)

CCL19 reduces tumour burden in a model of advanced lung cancer
por: Hillinger, S, et al.
Publicado: (2006)

A Study of IFN-α-Induced Chemokines CCL2, CXCL10 and CCL19 in Patients with Systemic Lupus Erythematosu
por: Geneva-Popova, Mariela Gencheva, et al.
Publicado: (2022)

IFN-γ, IL-2, IP-10, and MIG as Biomarkers of Exposure to Leishmania spp., and of Cure in Human Visceral Leishmaniasis
por: Ibarra-Meneses, Ana V., et al.
Publicado: (2017)

Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome
por: Caldarale, Francesca, et al.
Publicado: (2021)

Dipyrithione inhibits IFN-γ-induced JAK/STAT1 signaling pathway activation and IP-10/CXCL10 expression in RAW264.7 cells
por: Han, Cui, et al.
Publicado: (2010)

The chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia
por: Branch, Donald R., et al.
Publicado: (2022)

CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications
por: Liu, Mingli, et al.
Publicado: (2011)

Macrophages induce differentiation of plasma cells through CXCL10/IP-10
por: Xu, Wei, et al.
Publicado: (2012)

Cognitive Status Correlates with CXCL10/IP-10 Levels in Parkinson's Disease
por: Rocha, Natália Pessoa, et al.
Publicado: (2014)

IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer
por: Lunardi, Serena, et al.
Publicado: (2015)

Synergistic Up-Regulation of CXCL10 by Virus and IFN γ in Human Airway Epithelial Cells
por: Oslund, Karen L., et al.
Publicado: (2014)

Benzylideneacetophenone derivatives attenuate IFN-γ-induced IP-10/CXCL10 production in orbital fibroblasts of patients with thyroid-associated ophthalmopathy through STAT-1 inhibition
por: Lee, Sung-Hee, et al.
Publicado: (2014)

Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells
por: Riedl, Karen, et al.
Publicado: (2003)

BCA-1 (CXCL13) and SLC (CCL21) production and lymphoid neogenesis in rheumatoid synovitis
por: Manzo, A, et al.
Publicado: (2003)

IFN-γ and TNF-α drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 and other diseases with tissue inflammation
por: Zhang, Fan, et al.
Publicado: (2020)

CCL2 and CXCL10 are associated with poor outcome after intracerebral hemorrhage
por: Landreneau, Margaret J., et al.
Publicado: (2018)

Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8/IL-8 and CXCL10/IP-10
por: Vujanovic, Lazar, et al.
Publicado: (2012)

CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
por: Wang, Cuini, et al.
Publicado: (2016)

Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line
por: Matsumoto, Ari, et al.
Publicado: (2023)

HIV-1 Tat Co-Operates with IFN-γ and TNF-α to Increase CXCL10 in Human Astrocytes
por: Williams, Rachel, et al.
Publicado: (2009)

MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines
por: Berthoud, Tamara K., et al.
Publicado: (2009)

Association of circulating CXCL10 and CXCL11 with systemic sclerosis
por: Crescioli, Clara, et al.
Publicado: (2018)

IFN-γ and TNF-α drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation
por: Zhang, Fan, et al.
Publicado: (2021)

Overproduction of CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 in β-thalassemia major or patients
por: Najmaddini, Hamid, et al.
Publicado: (2014)

CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
por: Yu, Xin, et al.
Publicado: (2022)

CXCL8, CXCL9, and CXCL10 serum levels increase in syphilitic patients with seroresistance
por: Dong, Xiaoyan, et al.
Publicado: (2021)

Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN–driven CCL5 and CXCL10
por: Mowat, Courtney, et al.
Publicado: (2021)

CXCL4 and CXCL10 Predict Risk of Fatal Cerebral Malaria
por: Wilson, Nana O., et al.
Publicado: (2011)

Platelet Response to Allergens, CXCL10, and CXCL5 in the Context of Asthma
por: Gruba, Sarah, et al.
Publicado: (2022)

The Effect of Transplantation of Cultured Autologous Melanocytes on CXCL9, CXCL10 and CXCL11 Expressions in Vitiligo
por: Xu, Chen, et al.
Publicado: (2023)

CXCL10/IP-10 Neutralization Can Ameliorate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats
por: Lang, Shan, et al.
Publicado: (2017)

RSV Infection in Human Macrophages Promotes CXCL10/IP-10 Expression during Bacterial Co-Infection
por: Machado, Daniela, et al.
Publicado: (2017)

PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach
por: D'Arcangelo, Daniela, et al.
Publicado: (2016)

Serum CXCL10/IP-10 may be a potential biomarker for severe Mycoplasma pneumoniae pneumonia in children
por: Li, Mengyao, et al.
Publicado: (2021)

Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients
por: Bergamaschi, Cristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fifcfkmo4mpa7nhuograr128ru